Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes

被引:146
作者
Locati, M
Deuschle, U
Massardi, ML
Martinez, FO
Sironi, M
Sozzani, S
Bartfai, T
Mantovani, A
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Univ Milan, Ist Patol Gen, I-20122 Milan, Italy
[3] Hoffmann La Roche Ag, Div Pharma, Preclin Ctr Natl Sci Res, CH-4002 Basel, Switzerland
[4] Univ Brescia, Dept Biotechnol & Biomed Sci, Sect Gen Pathol & Immunol, Brescia, Italy
关键词
D O I
10.4049/jimmunol.168.7.3557
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The gene expression profile induced by the CC chemokine ligand (CCL) 5/RANTES in human monocytes was examined using the oligonucleotide array technology. Of 5600 transcripts examined, 42 were consistently induced by CCL5, and none were suppressed. Chemokine-inducible transcripts could be clustered in functional groups, including selected cytokines and receptors (e.g., IL-1beta, CCL2/monocyte chemotactic protein-1, and the CCL5 receptor CCR1) and molecules involved in extracellular matrix recognition and digestion (e.g., CD44 splice transcripts, urokinase-type plasminogen activator receptor, matrix metalloprotease (MMP)-9, and MMP-19). Transcript expression, confirmed by quantitative real-time PCR analysis for selected genes, was associated with protein induction for some (e.g., CCL2), but not all (e.g., IL-1beta), transcripts examined. The chemokine-induced gene profile was distinct from that activated by LPS, a prototypic phagocyte activator. Although certain transcripts were stimulated by both agonists (e.g., IL-1beta and CCL2), others were induced only by either LPS (e.g., TNF-alpha and IL-6) or CCL5 (e.g., MMP-19) or were divergently regulated (e.g., CCR1). Thus, CCL5, a prototypic CC inflammatory chemokine, activates a restricted transcriptional program in monocytes distinct from that induced by the prototypic pathogen-derived proinflammatory stimulant LPS. Chemokine-induced chemokines production could represent a novel amplification loop of leukocyte recruitment, while a subset of chemokine-inducible transcripts could be involved in monocyte extravasation and tissue invasion.
引用
收藏
页码:3557 / 3562
页数:6
相关论文
共 33 条
  • [1] Alexander DL, 1997, CANCER RES, V57, P4498
  • [2] CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
    Aliberti, J
    Sousa, CRE
    Schito, M
    Hieny, S
    Wells, T
    Huffnagle, GB
    Sher, A
    [J]. NATURE IMMUNOLOGY, 2000, 1 (01) : 83 - 87
  • [3] Cytochrome P450 1B1:: A major P450 isoenzyme in human blood monocytes and macrophage subsets
    Baron, JM
    Zwadlo-Klarwasser, G
    Jugert, F
    Hamann, W
    Rübben, A
    Mukhtar, H
    Merk, HF
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 56 (09) : 1105 - 1110
  • [4] uPA, uPAR, PAI-I: key intersection of proteolytic, adhesive and chemotactic highways?
    Blasi, F
    [J]. IMMUNOLOGY TODAY, 1997, 18 (09): : 415 - 417
  • [5] Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
    Boring, L
    Gosling, J
    Cleary, M
    Charo, IF
    [J]. NATURE, 1998, 394 (6696) : 894 - 897
  • [6] Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
    Boring, L
    Gosling, J
    Chensue, SW
    Kunkel, SL
    Farese, RV
    Broxmeyer, HE
    Charo, IF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) : 2552 - 2561
  • [7] Selective suppression of IL-12 production by chemoattractants
    Braun, MC
    Lahey, E
    Kelsall, BL
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (06) : 3009 - 3017
  • [8] Dominant myelopoietic effector functions mediated by chemokine receptor CCR1
    Broxmeyer, HE
    Cooper, S
    Hangoc, G
    Gao, JL
    Murphy, PM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) : 1987 - 1992
  • [9] Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
    Fambrough, D
    McClure, K
    Kazlauskas, A
    Lander, ES
    [J]. CELL, 1999, 97 (06) : 727 - 741
  • [10] Goetzl EJ, 1996, J IMMUNOL, V156, P1